← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 27.1% to $211.1M, while Net income increased 39.6% to ($51.1M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $211.1MWatch
- Profitability — Net income ($51.1M)Watch
- Cash generation — Free cash flow ($56.9M)Note
- Accounting — Formula distress score · no manipulation flag · earnings quality safeWatch
- Insiders — 3 buys; 13 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Business
ESTABLISHMENT LABS HOLDINGS INC.: If our available cash resources and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements, we may seek to sell equity or convertible debt securities, enter into a credit facility or another form of third-party funding, or seek other debt financing.
Leadership changes
From ESTABLISHMENT LABS HOLDINGS INC.'s own filings, the day they're filed.
- Taylor Harris · Directors · appointmenteff. 2026-06-24
- Paul D. Rodio · Chief Operating Officer · departureeff. 2023-12-08
- Juan Jos Chac · Chief Executive Officer · departure
Latest filings
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-29
- 8-K · Company announcement2026-05-22
- 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ESTABLISHMENT LABS HOLDINGS INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.